Cite
HARVARD Citation
Battat, R. et al. (2019). Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis. Inflammatory bowel diseases. 25 (2), pp. 410-420. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Battat, R. et al. (2019). Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis. Inflammatory bowel diseases. 25 (2), pp. 410-420. [Online].